Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CRISABOROLE vs ROFLUMILAST: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CRISABOROLE vs ROFLUMILAST: Safety Overview

Metric CRISABOROLE ROFLUMILAST
Total FAERS Reports 7,784 2,700
Deaths Reported 22 645
Death Rate 0.3% 23.9%
Hospitalizations 53 625
Average Patient Age 39.7 yrs 68.8 yrs
% Female Patients 65.9% 56.3%
FDA Approval Date Dec 14, 2016 Apr 17, 2023
Manufacturer Pfizer Laboratories Div Pfizer Inc Aurobindo Pharma Limited
Route TOPICAL ORAL
Marketing Status Prescription Prescription